|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-3-1
|
|
pubmed:abstractText |
Chemotherapy administered as a continuous infusion is a widely used treatment in oncology. Huber needle deserves close attention during chemotherapy, but no data are reported on how long it can be left in situ without change. We therefore evaluated the feasibility of leaving in situ the needle for a prolonged time.
|
|
pubmed:language |
ita
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
N
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0033-0205
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
71-4
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11272087-Antineoplastic Agents,
pubmed-meshheading:11272087-Catheters, Indwelling,
pubmed-meshheading:11272087-Hospitalization,
pubmed-meshheading:11272087-Humans,
pubmed-meshheading:11272087-Infusions, Intra-Arterial,
pubmed-meshheading:11272087-Infusions, Parenteral,
pubmed-meshheading:11272087-Needles,
pubmed-meshheading:11272087-Research,
pubmed-meshheading:11272087-Time Factors
|
|
pubmed:articleTitle |
[Huber needle in situ inpatients under continuous infusion chemotherapy: results of a study, Phase II].
|
|
pubmed:affiliation |
Divisione di Oncologia Medica, Instituto Europeo di Oncologia, Milano, Italia.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
